Cytotoxic and proapoptotic effects of new Pd(II) and Pt(II)-complexes with 2-ethanimidoyl-2-methoxy-2H-1,2-benzoxaphosphinin-4-ol-2-oxide

Polish Journal of Pharmacology

Volumn 56, Issue 4, 2004, Pages 473-478

  Budzisz, Elzbieta ^a   Krajewska, Urszula ^a   Rózalski, Marek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Cytotoxicity; Palladium (II) and Platinum (II) complexes; Phosphonic analogues of coumarin

Indexed keywords

3 ETHANIMIDOYL 2 METHOXY 2H 1,2 BENZOXAPHOSPININ 4 OL 2 OXIDE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CASPASE 3; CISPLATIN; PALLADIUM COMPLEX; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INDUCTION; HUMANS; IMIDES; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOPLATINUM COMPOUNDS; PALLADIUM; PLATINUM; TIME FACTORS;

EID: 9744246058     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Budzisz E, Keppler BK, Giester G, Woźniczka M, Kufelnicki A, Nawrot B: Synthesis, crystal structure and biological characterization of novel palladium (II) complex with coumarin - derived ligand. Eur J Inorg Chem, in press.
2. Budzisz E, Pastuszko S: Reaction of dimethyl-2-methyl- and dimethyl-2-phenyl-4-oxo-4H-chromen-3-yl-phosphonate with amines. Tetrahedron, 1999, 55, 4815-4825.
3. Drexler HG, Dirks W, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC: DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen Catalogue of Human and Animal Cell Lines. 8th edn., DSMZ Publ., Braunschweig, 2001.
4. Egorin MJ, Van Echo DA, Tipping SJ: Pharmacokinetics and dose reduction of cis-diammone(1,1-cyclobutane-dicarboxylato)-platinum in patients with impaired renal function. Cancer Res, 1984, 44, 5432-5438.
5. Galanski M, Arion VB, Jakupec MA, Keppler BK: Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des, 2003, 9, 2078-2089.
6. Go RS, Adjei AA: Review of comparative pharmacology and clinical activity of cis-platin and carboplatin. J Clin Oncol, 1999, 17, 409-422.
7. Hale AJ, Smith ChA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT: Apoptosis: molecular regulation of cell death. Eur J Biochem, 1996, 236, 1-26.
8. Heim ME: Platinum and non-platinum complexes in clinical trials. Current status and new developments. In: Metal Complexes in Cancer Chemotherapy. Ed. Keppler BK, VCH, Weinheim, 1993, 9-24.
9. Jakupec MA, Galanski M, Keppler BK: Tumor-inhibiting platinum complexes - state of the art and future perspectives. Rev Physiol Biochem Pharmacol, 2003, 146, 1-53.
10. Knox RJ, Friedlos F, Lydall DA: Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis diaminedichloroplatinum (II) and cis-diamine-(1,1-cyclobutanedicarboxylato)platinum (II) differ only in kinetics of their interaction with DNA. Cancer Res, 1986, 46, 1972-1979.
11. Kostova I, Manolov I, Karaivanova M: Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives. Arch Pharm (Weinheim), 2001, 334, 157-162.
12. Mirowski M, Rózalski M, Krajewska U, Balcerczak E, Młynarski W, Wierzbicki R: Induction of caspase 3 and modulation of some apoptotic genes in human acute promyelocytic leukemia HL-60 cells by carboplatin with amifostine. Pol J Pharmacol, 2003, 55, 227-234.
13. Nagata S: Apoptotic DNA fragmentation. Exp Cell Res, 2000, 256, 12-18.
14. Rosenberg B, Van Camp L, Trosko JE, Mansour VH: Platinum compounds: a new class of potent antitumor agents. Nature, 1969, 222, 385-386.
15. Shehata MR: Mixed ligand complexes of diaquo (2,2′-bipyridine)palladium(II) with cyclobutane-1,1-dicarboxylic acid and DNA constituents. Trans Met Chem, 2001, 26, 198-204.
16. Van Kralingen CG, De Ridder JK, Reedijk J: Coordination compounds of Pt(II) and Pd(II) with imidazole as a ligand. New synthetic procedures and characterization. Inorg Chim Acta, 1979, 36, 69-73.
17. Weber US, Steffen B, Sigers C: Antitumor activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. Res Commun Mol Pathol Pharmacol, 1998, 99, 193-206.
18. Wong E, Giandomenico CM: Current status od platinum-based antitumor drugs. Chem Rev, 1999, 99, 2451-2466.